abstract |
The present disclosure provides biological scaffolds, methods for their synthesis and methods for their use. The biological scaffolds contain at least to components, the first, a mammalian cell platelet lysate and an adipose tissue-derived cell fraction (ATDCF) cell. Products that comprise the biological scaffold(s) may be a gel, a semi-solid or a solid substrate upon which at least one surface of the substrate is contacted with the biological scaffold to form a biocompatible material. The biological scaffold and biological scaffold containing products, can find utility in a vast range of medical device technologies and may be used for therapeutic purposes or for performing experimentation to test various pharmacological agents in vitro and in vivo. |